Wellington Management Group’s Freeline Therapeutics Holdings FRLN Stock Holding History
Bought
Maintained
Sold
Other funds holding FRLN
Wellington Management Group's FRLN Position: Q1 2022 in Review
Wellington Management Group sold out of Freeline Therapeutics Holdings (FRLN) in Q1 2022, closing a stake of 29,320 shares — an estimated $866K sold.
Wellington Management Group first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $42.9M in Q4 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.
- Wellington Management Group reported no remaining Freeline Therapeutics Holdings position as of Q1 2022 after selling out during the quarter.
- Wellington Management Group sold 29,320 Freeline Therapeutics Holdings shares in Q1 2022, an estimated $866K.
- Wellington Management Group first reported a position in Freeline Therapeutics Holdings in Q3 2020 and held it in 6 quarters.
- Wellington Management Group's Freeline Therapeutics Holdings position peaked at $42.9M in Q4 2020.
- 19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q1 2022.
Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.